Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Mark Marcellus who wrote (2441)	3/30/2000 9:35:00 PM
From: Mike M	Read Replies (2) \| Respond to of 5582

Mark you may believe what you want. Interestingly folks using Zicam continued to report that it helped with their allergies... The product was developed around the gel matrix (rather than the zinc-Hank)...It has been clinically tested and works. Your point about competing with the big boys is a valid one. I do imagine that the cost of the product would be very competitive. But, more importantly, it would really help if they shared with the big boys...I think Warner Lambert has acquired a homeopathic company. It wouldn't surprise me if one of the big boys bought into Zicam...That could change the odds significantly. Enjoy the ride!